Form 8-K - Current report:
SEC Accession No. 0001023024-06-000021
Filing Date
2006-07-10
Accepted
2006-07-10 16:59:22
Documents
5
Period of Report
2006-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 8K FOR PIPE 7-10-06 biosante8kforpipe.htm 8-K 42991
2 SUBSCRIPTION AGREEMENT subagreement.htm EX-10.1 225311
3 FORM OF WARRANT formofwarrant.htm EX-10.2 99322
4 PRESS RELEASE pressrelease.htm EX-99.1 16336
5 BIOSANTE LOGO biosantelogo6.jpg GRAPHIC 12999
  Complete submission text file 0001023024-06-000021.txt   403725
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 06954435
SIC: 2836 Biological Products, (No Diagnostic Substances)